8 completed, 1 terminated. 9 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 8, Terminated 1 |
Follow bromfenac: new trials by email Literature Review of bromfenac trials Research Report on bromfenac
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness of Periocular Drug Injection in CATaract Surgery Bromfenac, Dexamethasone, Triamcinolone Acetonide - Macular Edema, Cystoid Macular Edema | Phase 3 | Terminated | Luigi Rondas | 628 | 2021-10-13 | 2024-11-04 |
| PGE2 Levels in Patient Treated With NSAIDs Placebo, Dicloftil, Nevanac - Ocular Inflammation | Phase 3 | Completed | University of Trieste | 104 | 2018-04-25 | 2018-07-24 |
| NSAIDs and PGE2 Levels in Vitrectomy Patients Ketorolac 0.5% eyedrops, Indomethacin 0.5% eyedrops, Bromfenac 0.09% eyedrops - Vitreous Inflammation | Phase 3 | Completed | Università degli Studi di Brescia | 70 | 2014-03-01 | 2015-02-12 |
| PRevention of Macular EDema After Cataract Surgery Bromfenac, Dexamethasone, Bevacizumab - Cystoid Macular Edema, Cataract | Phase 3 | Completed | Maastricht University Medical Center | 1127 | 2013-07-10 | 2017-04-14 |
| Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects ISV-303, DuraSite Vehicle - Ocular Inflammation | Phase 3 | Completed | Sun Pharmaceutical Industries Limited | 268 | 2013-05-01 | 2021-11-19 |
| Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects ISV-303, DuraSite Vehicle - Ocular Inflammation | Phase 3 | Completed | Sun Pharmaceutical Industries Limited | 268 | 2012-07-01 | 2021-11-19 |
| Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery Bromfenac, Placebo - Cataract | Phase 3 | Completed | Bausch & Lomb Incorporated | 156 | 2008-06-01 | 2013-01-18 |
| Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis Bromfenac, Placebo - Allergic Conjunctivitis | Phase 3 | Completed | Bausch & Lomb Incorporated | 90 | 2006-11-01 | 2013-03-14 |
| Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery Bromfenac, Placebo - Postoperative Complications, Cataract | Phase 3 | Completed | Bausch & Lomb Incorporated | 527 | 2003-05-01 | 2013-03-14 |
Cataract (4) · Macular Edema (2) · Conjunctivitis, Allergic (1) · Diabetes Mellitus (1) · Epiretinal Membrane (1) · Eye Diseases (1) · Lens Diseases (1) · Postoperative Complications (1) · Retinal Diseases (1) · Retinal Perforations (1)
Bausch & Lomb Incorporated (3) · Sun Pharmaceutical Industries Limited (2) · Luigi Rondas (1) · Maastricht University Medical Center (1) · University of Trieste (1) · Università degli Studi di Brescia (1)
United States (3) · Austria (2) · Germany (2) · Netherlands (2) · Portugal (2) · Belgium (1) · Hungary (1) · Italy (1) · Spain (1)
Jon Williams, PhD (1) · Lisa R Grillone, PhD (1) · Marco R Pastore, MD (1) · Nienke Visser, Dr. (1) · prof. Rudy MM Nuijts, MD, PhD (1)
PMID 21751945, PMID 33009281, PMID 33595256, PMID 34417781
2019 (1)